soma chems bpc 157 BPC-157-5-mg-Vial-Soma-Peptides-600x600.png BPC 157 (Body Protection Compound-157)

Cagrilintide Also known as: NN9838, AM833 Cagrilintide is a long-acting acylated amylin analog developed by Novo Nordisk, designed for once-weekly subcutaneous administration and studied both as monotherapy and in combination with semaglutide (CagriSema) for obesity and type 2 diabetes management

multiple organ lesions, i.e., the heart dilatation, myocardial congestion and confluent areas of subendocardial ischemic myocytes, ECG disturbances (i.e., giant T-wave)

Science 361 , eaat5236 (2018)

Fibrosis The pathognomic finding of PSC, that is, onion skin scars, appears as peribiliary circumferential fibrosis layers, causing fibrous obliteration of the bile duct